PL446430A1 - Osocze bogatopłytkowe PRP i sposób jego przechowywania - Google Patents

Osocze bogatopłytkowe PRP i sposób jego przechowywania

Info

Publication number
PL446430A1
PL446430A1 PL446430A PL44643023A PL446430A1 PL 446430 A1 PL446430 A1 PL 446430A1 PL 446430 A PL446430 A PL 446430A PL 44643023 A PL44643023 A PL 44643023A PL 446430 A1 PL446430 A1 PL 446430A1
Authority
PL
Poland
Prior art keywords
platelet
platelets
rich plasma
plasma
prp
Prior art date
Application number
PL446430A
Other languages
English (en)
Inventor
Tomasz Walski
Natalia Trochanowska-Pauk
Krystian Kubica
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL446430A priority Critical patent/PL446430A1/pl
Publication of PL446430A1 publication Critical patent/PL446430A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Wynalazek ujawnia osocze bogatopłytkowe PRP, które zawiera płytki krwi, osocze lub substytuty osocza i ich kombinacje oraz środek hamujący odwracalnie agregację płytek jest obecnych w stężeniu (0-100mM) umożliwiającym zachowanie płytek krwi in vitro i zachowanie aktywności funkcjonalnej płytek krwi, po ich rozrzedzeniu. Wynalazek ujawnia również sposób przechowywania osocza bogatopłytkowego PRP polegający na tym, że po izolacji płytek krwi z krwi pobranej od dawców, preparat płytkowy jest zabezpieczany przed agregacją za pomocą związku chemicznego – (1S,2S,3R,5S)-3-{[(1R,2S)-2-(3,4-difluorofenyl)cyklopropyl]amino}-5-(propyltio)-3H-[1,2,3]-triazolo[4,5-d]pirymidin-3-yl]-5-(2-hydroksyetoksy)cyklopentan-1,2-diol w stężeniu od 0,01 mmol/dm3 do 1 mol/dm3,który blokuje odwracalnie receptory P2Y12 płytek krwi zabezpieczając je przed agregacją, co umożliwia bezpieczne przechowywanie preparatów płytkowych powyżej 5 dni, w temperaturze pokojowej, w warunkach ciągłego mieszania.
PL446430A 2023-10-19 2023-10-19 Osocze bogatopłytkowe PRP i sposób jego przechowywania PL446430A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL446430A PL446430A1 (pl) 2023-10-19 2023-10-19 Osocze bogatopłytkowe PRP i sposób jego przechowywania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446430A PL446430A1 (pl) 2023-10-19 2023-10-19 Osocze bogatopłytkowe PRP i sposób jego przechowywania

Publications (1)

Publication Number Publication Date
PL446430A1 true PL446430A1 (pl) 2025-04-22

Family

ID=95451092

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446430A PL446430A1 (pl) 2023-10-19 2023-10-19 Osocze bogatopłytkowe PRP i sposób jego przechowywania

Country Status (1)

Country Link
PL (1) PL446430A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919614A (en) * 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
WO2015109220A1 (en) * 2014-01-17 2015-07-23 President And Fellows Of Harvard College Platelet decoy and use thereof
WO2016022433A1 (en) * 2014-08-07 2016-02-11 The General Hospital Corporation Stabilization of whole blood samples

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919614A (en) * 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
WO2015109220A1 (en) * 2014-01-17 2015-07-23 President And Fellows Of Harvard College Platelet decoy and use thereof
WO2016022433A1 (en) * 2014-08-07 2016-02-11 The General Hospital Corporation Stabilization of whole blood samples

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WALSKI, T., GRZESZCZUK-KUĆ, K., GAŁECKA, K., I IN.: "Scientific Reports (2022) 12, 1–12", NEAR-INFRARED PHOTOBIOMODULATION OF BLOOD REVERSIBLY INHIBITS PLATELET REACTIVITY AND REDUCES HEMOLYSIS,, DOI: doi.org/10.1038/s41598-022-08053-y *

Similar Documents

Publication Publication Date Title
CN110382515B (zh) 经修饰的环状二核苷酸化合物
FI4013755T3 (fi) Piperidinyylimetyylipuriiniamiineja nsd2:n estäjinä ja syöpälääkkeinä
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
AU2015274635B2 (en) Phosphatidylinositol 3-kinase inhibitors
CA2724192C (en) Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors
JP2020536069A5 (pl)
CA2952025A1 (en) Phosphatidylinositol 3-kinase inhibitors
AU2015274637B2 (en) Phosphatidylinositol 3-kinase inhibitors
HUP0105081A2 (hu) Triazolo[4,5-d]pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
PE20161066A1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
IL283368B1 (en) An imidazo[1,2-b]pyridazin-7-yl-urea compound and a medicine comprising the compound
RS61423B1 (sr) Ciklična dinukleotidna jedinjenja
SI2935238T1 (en) On aryl and heteroaryl fused lactams
TW201618773A (zh) Ｂｔｋ抑制劑、ｐｉ３ｋ抑制劑、ｊａｋ－２抑制劑、及／或ｃｄｋ４／６抑制劑的治療組合物
TW201618772A (zh) Ｂｔｋ抑制劑、ｐｉ３ｋ抑制劑、ｊａｋ－２抑制劑及／或ｂｃｌ－２抑制劑之治療組合物
CA2906085A1 (en) P2x7 modulators
EP2499143B1 (en) N7-substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
RU2012142730A (ru) Соединения, композиции и способы для снижения или устранения горького вкуса
CA2516699A1 (en) Hiv replication inhibiting pyrimidines and triazines
RU2014126750A (ru) Ингибиторы тирозинкиназы брутона
JPH0393783A (ja) 置換スルホニルアミノアゾール類
TW202228787A (zh) 吡咯并苯二氮平—抗體結合物及其用途
CA2976766A1 (en) Formylated n-heterocyclic derivatives as fgfr4 inhibitors
PL446430A1 (pl) Osocze bogatopłytkowe PRP i sposób jego przechowywania
JP2012524103A5 (pl)